This effect is associated with PPAR-γ agonism, as it improved insulin resistance and reduced dyslipidemia and polydipsia, without causing hepatotoxicity or other relevant adverse effects, although 8d did not show intrinsic antioxidant or anti-inflammatory activity in the evaluated model. The gene discussed is PPARG; the disease is Polydipsia.